512 related articles for article (PubMed ID: 11654611)
1. Conflict of interest in human research ethics.
Jones DJ
NCBHR Commun; 1995; 6(2):5-10. PubMed ID: 11654611
[No Abstract] [Full Text] [Related]
2. Research fraud, misconduct, and the IRB.
Hilgartner S
IRB; 1990; 12(1):1-4. PubMed ID: 11651971
[No Abstract] [Full Text] [Related]
3. Divided loyalties: an anthology of conflict of interest duties.
National Council on Bioethics in Human Research (Canada). Office
NCBHR Commun; 1995; 6(2):11-6. PubMed ID: 11654610
[No Abstract] [Full Text] [Related]
4. The Ethics of Human Experimentation: Reinventing the Research Ethics Board: Proceedings of a National Workshop held in Ottawa, Ontario, March 5-6, 1995.
National Council on Bioethics in Human Research (Canada)
NCBHR Commun; 1996; 7(1):5-35. PubMed ID: 11654527
[No Abstract] [Full Text] [Related]
5. Sharing scientific data II: normative issues.
Weil V; Hollander R
IRB; 1990; 12(2):7-8. PubMed ID: 11650369
[No Abstract] [Full Text] [Related]
6. Money is putting people at risk in biomedical research.
Andrews LB
Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
[No Abstract] [Full Text] [Related]
7. Informed consent in human experimentation: bridging the gap between ethical thought and current practice.
Delgado R; Leskovac H
UCLA Law Rev; 1986 Oct; 34(1):67-130. PubMed ID: 11659049
[No Abstract] [Full Text] [Related]
8. Informed consent process is deemed "legally and ethically invalid" by witness.
Maloney DM
Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008
[No Abstract] [Full Text] [Related]
9. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper.
High DM; Whitehouse PJ; Post SG; Berg L
Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):66-74. PubMed ID: 11657676
[No Abstract] [Full Text] [Related]
10. Whistleblowing in biomedical research: report from a workshop.
Mishkin B
IRB; 1982 Feb; 4(2):8-9. PubMed ID: 11658314
[No Abstract] [Full Text] [Related]
11. NZ medicine after Cartwright.
Gillett G
BMJ; 1990 Apr; 300(6729):892-4. PubMed ID: 11642768
[No Abstract] [Full Text] [Related]
12. Is post-marketing drug follow-up research or advertising?
Weiss GB; Winslade WJ
IRB; 1987; 9(4):10-1. PubMed ID: 11649947
[No Abstract] [Full Text] [Related]
13. The case for per patient payments.
Lewis JP
IRB; 1988; 10(5):9. PubMed ID: 11650075
[No Abstract] [Full Text] [Related]
14. Developing a Tri-Council code of conduct for research involving humans.
Rolleston F; Armour C; Stipich N
J Int Bioethique; 1997; 8(1-2):67-70. PubMed ID: 11655381
[No Abstract] [Full Text] [Related]
15. Structuring the review of human genetics protocols: gene localization and identification studies.
Glass KC; Weijer C; Palmour RM; Shapiro SH; Lemmens TM; Lebacqz K
IRB; 1996; 18(4):1-9. PubMed ID: 11654877
[No Abstract] [Full Text] [Related]
16. Health Sciences Council of Japan adopts guidelines for gene therapy clinical research.
Int Dig Health Legis; 1995; 46(4):560-3. PubMed ID: 11657358
[No Abstract] [Full Text] [Related]
17. Criminal liability for misconduct in scientific research.
Kuzma SM
Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
[No Abstract] [Full Text] [Related]
18. Encouraging accountability in research: a pilot assessment of training efforts.
Mastroianni AC; Kahn JP
Account Res; 1999; 7(1):85-100. PubMed ID: 11657564
[No Abstract] [Full Text] [Related]
19. The search for a cure: combating the problem of conflicts of interest that currently plagues biomedical research.
Clamon JB
Iowa Law Rev; 2003 Oct; 89(1):235-71. PubMed ID: 15732180
[No Abstract] [Full Text] [Related]
20. On being an authentic scientist.
Smith ML
IRB; 1992; 14(2):1-4. PubMed ID: 11651243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
